(-)-demecolcine decreases expression ISO RGD:1607086 6480464 Demecolcine results in decreased expression of SKP2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1607086 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SKP2 mRNA CTD PMID:22079256 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1552631 6480464 Dinitrochlorobenzene results in increased expression of SKP2 mRNA CTD PMID:21404309 17alpha-ethynylestradiol multiple interactions ISO RGD:1552631 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKP2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1607086 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SKP2 mRNA more ... CTD PMID:23029392 , PMID:30165855 17beta-estradiol increases response to substance ISO RGD:1607086 6480464 SKP2 protein results in increased susceptibility to Estradiol CTD PMID:23029392 17beta-estradiol increases expression ISO RGD:1607086 6480464 Estradiol results in increased expression of SKP2 protein CTD PMID:23029392 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552631 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKP2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552631 6480464 Tetrachlorodibenzodioxin affects the expression of SKP2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1607086 6480464 Tetrachlorodibenzodioxin results in decreased expression of SKP2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552631 6480464 Tetrachlorodibenzodioxin results in increased expression of SKP2 mRNA CTD PMID:19465110 2-butoxyethanol increases expression ISO RGD:1552631 6480464 n-butoxyethanol results in increased expression of SKP2 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1607086 6480464 beta-methylcholine affects the expression of SKP2 mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol increases expression ISO RGD:1607086 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SKP2 mRNA CTD PMID:25912373 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1552631 6480464 Oxazolone results in increased expression of SKP2 mRNA CTD PMID:21404309 4-nitrophenol decreases expression ISO RGD:1552631 6480464 4-nitrophenol results in decreased expression of SKP2 mRNA CTD PMID:34673133 acetamide increases expression EXP 6480464 acetamide results in increased expression of SKP2 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1607086 6480464 Aflatoxin B1 results in decreased expression of SKP2 mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin B1 decreases methylation ISO RGD:1607086 6480464 Aflatoxin B1 results in decreased methylation of SKP2 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:1607086 6480464 Tretinoin results in decreased expression of SKP2 mRNA, Tretinoin results in decreased expression of SKP2 protein CTD PMID:15498508 more ... all-trans-retinoic acid multiple interactions ISO RGD:1607086 6480464 [Tretinoin results in increased ubiquitination of and results in increased degradation of SKP2 protein] which results in increased expression of CDKN1B protein, Tretinoin results in increased ubiquitination of and results in increased degradation of SKP2 protein CTD PMID:11595732 all-trans-retinoic acid decreases response to substance ISO RGD:1607086 6480464 SKP2 protein results in decreased susceptibility to Tretinoin CTD PMID:11595732 arachidonic acid decreases expression ISO RGD:1607086 6480464 Arachidonic Acid results in decreased expression of SKP2 mRNA CTD PMID:16704987 aristolochic acid A decreases expression ISO RGD:1607086 6480464 aristolochic acid I results in decreased expression of SKP2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1607086 6480464 Arsenic affects the methylation of SKP2 gene CTD PMID:25304211 arsane multiple interactions ISO RGD:1607086 6480464 UCA1 mRNA promotes the reaction [Arsenic results in decreased expression of SKP2 protein] CTD PMID:29248574 arsane decreases expression ISO RGD:1607086 6480464 Arsenic results in decreased expression of SKP2 mRNA CTD PMID:29248574 arsenic atom affects methylation ISO RGD:1607086 6480464 Arsenic affects the methylation of SKP2 gene CTD PMID:25304211 arsenic atom decreases expression ISO RGD:1607086 6480464 Arsenic results in decreased expression of SKP2 mRNA CTD PMID:29248574 arsenic atom multiple interactions ISO RGD:1607086 6480464 UCA1 mRNA promotes the reaction [Arsenic results in decreased expression of SKP2 protein] CTD PMID:29248574 arsenite(3-) affects expression ISO RGD:1607086 6480464 arsenite affects the expression of SKP2 mRNA CTD PMID:22959463 arsenous acid increases expression ISO RGD:1552631 6480464 Arsenic Trioxide results in increased expression of SKP2 mRNA CTD PMID:29095437 arsenous acid decreases expression ISO RGD:1607086 6480464 Arsenic Trioxide results in decreased expression of SKP2 protein CTD PMID:25174355 , PMID:25335113 arsenous acid multiple interactions ISO RGD:1552631 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of SKP2 mRNA] CTD PMID:29095437 atrazine increases expression ISO RGD:1552631 6480464 Atrazine results in increased expression of SKP2 protein CTD PMID:33766575 azathioprine decreases expression ISO RGD:1607086 6480464 Azathioprine results in decreased expression of SKP2 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1607086 6480464 Benzo(a)pyrene results in decreased expression of SKP2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1607086 6480464 Benzo(a)pyrene results in increased expression of SKP2 mRNA CTD PMID:33411230 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1607086 6480464 7 more ... CTD PMID:20382639 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1607086 6480464 Mustard Gas results in decreased expression of SKP2 mRNA CTD PMID:25102026 bisphenol A decreases expression ISO RGD:1552631 6480464 bisphenol A results in decreased expression of SKP2 mRNA CTD PMID:25270620 , PMID:26063408 bisphenol A affects expression ISO RGD:1607086 6480464 bisphenol A affects the expression of SKP2 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SKP2 mRNA CTD PMID:25181051 more ... bortezomib decreases expression ISO RGD:1607086 6480464 Bortezomib results in decreased expression of SKP2 protein CTD PMID:18850583 , PMID:19636294 bortezomib multiple interactions ISO RGD:1607086 6480464 Cisplatin promotes the reaction [Bortezomib results in decreased expression of SKP2 protein] CTD PMID:19636294 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SKP2 mRNA CTD PMID:19167457 cadmium atom decreases expression ISO RGD:1607086 6480464 Cadmium results in decreased expression of SKP2 mRNA CTD PMID:21120746 cadmium dichloride increases expression ISO RGD:1552631 6480464 Cadmium Chloride results in increased expression of SKP2 mRNA CTD PMID:20061341 cadmium dichloride increases expression ISO RGD:1607086 6480464 Cadmium Chloride results in increased expression of SKP2 mRNA CTD PMID:26472689 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of SKP2 promoter CTD PMID:22457795 caffeine decreases phosphorylation ISO RGD:1607086 6480464 Caffeine results in decreased phosphorylation of SKP2 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1607086 6480464 Calcitriol results in decreased expression of SKP2 mRNA, Calcitriol results in decreased expression of SKP2 protein CTD PMID:12954644 , PMID:21592394 calcitriol multiple interactions ISO RGD:1607086 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SKP2 mRNA CTD PMID:21592394 calycosin decreases expression ISO RGD:1607086 6480464 7, 3'-dihydroxy-4'-methoxyisoflavone results in decreased expression of SKP2 mRNA CTD PMID:24455688 cannabidiol decreases expression ISO RGD:1607086 6480464 Cannabidiol results in decreased expression of SKP2 mRNA CTD PMID:33244087 , PMID:36519830 carbon nanotube increases expression ISO RGD:1552631 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1607086 6480464 CGP 52608 promotes the reaction [RORA protein binds to SKP2 gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO RGD:1552631 6480464 Chlorpyrifos results in decreased expression of SKP2 mRNA CTD PMID:20350560 cisplatin multiple interactions ISO RGD:1607086 6480464 Cisplatin promotes the reaction [Bortezomib results in decreased expression of SKP2 protein] CTD PMID:19636294 cobalt dichloride decreases expression ISO RGD:1607086 6480464 cobaltous chloride results in decreased expression of SKP2 mRNA CTD PMID:19320972 , PMID:19376846 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of SKP2 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1607086 6480464 [Chelating Agents binds to Copper] which results in decreased expression of SKP2 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of SKP2 mRNA CTD PMID:20971185 , PMID:30911355 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of SKP2 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1607086 6480464 [Chelating Agents binds to Copper] which results in decreased expression of SKP2 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of SKP2 mRNA CTD PMID:20971185 , PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1607086 6480464 Copper Sulfate results in decreased expression of SKP2 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1607086 6480464 coumarin affects the phosphorylation of SKP2 protein CTD PMID:35688186 coumestrol increases expression ISO RGD:1607086 6480464 Coumestrol results in increased expression of SKP2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1607086 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1607086 6480464 Cyclosporine results in decreased expression of SKP2 mRNA CTD PMID:20106945 more ... diarsenic trioxide multiple interactions ISO RGD:1552631 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of SKP2 mRNA] CTD PMID:29095437 diarsenic trioxide increases expression ISO RGD:1552631 6480464 Arsenic Trioxide results in increased expression of SKP2 mRNA CTD PMID:29095437 diarsenic trioxide decreases expression ISO RGD:1607086 6480464 Arsenic Trioxide results in decreased expression of SKP2 protein CTD PMID:25174355 , PMID:25335113 dibutyl phthalate decreases expression ISO RGD:1552631 6480464 Dibutyl Phthalate results in decreased expression of SKP2 mRNA CTD PMID:21266533 Didecyldimethylammonium decreases expression ISO RGD:1607086 6480464 didecyldimethylammonium results in decreased expression of SKP2 mRNA CTD PMID:32763356 dimethylarsinous acid increases expression ISO RGD:1607086 6480464 dimethylarsinous acid results in increased expression of SKP2 mRNA CTD PMID:19945496 dioxygen decreases expression ISO RGD:1607086 6480464 Oxygen results in decreased expression of SKP2 mRNA CTD PMID:27103661 dorsomorphin multiple interactions ISO RGD:1607086 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1607086 6480464 Doxorubicin affects the expression of SKP2 mRNA, Doxorubicin affects the expression of SKP2 protein CTD PMID:17893511 doxorubicin affects response to substance ISO RGD:1607086 6480464 SKP2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 endosulfan decreases expression ISO RGD:1607086 6480464 Endosulfan results in decreased expression of SKP2 mRNA CTD PMID:30090376 Enterolactone multiple interactions ISO RGD:1607086 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA CTD PMID:19167446 folic acid multiple interactions ISO RGD:1607086 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of SKP2 mRNA CTD PMID:24657277 formaldehyde decreases expression ISO RGD:1607086 6480464 Formaldehyde results in decreased expression of SKP2 mRNA CTD PMID:20655997 , PMID:23649840 fraxetin decreases expression ISO RGD:1607086 125097526 Fraxetin decreases expression of SKP2 mRNA and protein in colorectum RGD gamma-linolenic acid decreases expression ISO RGD:1607086 6480464 gamma-Linolenic Acid results in decreased expression of SKP2 mRNA CTD PMID:20664735 geraniol decreases expression ISO RGD:1607086 6480464 geraniol results in decreased expression of SKP2 mRNA CTD PMID:27683099 glyphosate decreases expression ISO RGD:1607086 6480464 glyphosate results in decreased expression of SKP2 mRNA CTD PMID:31295307 GW 3965 decreases expression ISO RGD:1607086 6480464 GW 3965 results in decreased expression of SKP2 mRNA CTD PMID:31437187 GW 4064 increases expression ISO RGD:1607086 6480464 GW 4064 results in increased expression of SKP2 mRNA CTD PMID:31437187 irinotecan increases response to substance ISO RGD:1607086 6480464 SKP2 protein results in increased susceptibility to Irinotecan CTD PMID:16734730 lactacystin multiple interactions ISO RGD:1607086 6480464 lactacystin inhibits the reaction [Estradiol results in increased expression of SKP2 protein] CTD PMID:23029392 lactacystin decreases expression ISO RGD:1607086 6480464 lactacystin results in decreased expression of SKP2 protein CTD PMID:23029392 leflunomide decreases expression ISO RGD:1607086 6480464 leflunomide results in decreased expression of SKP2 mRNA CTD PMID:28988120 metformin multiple interactions ISO RGD:1552631 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of SKP2 mRNA] CTD PMID:29095437 methotrexate decreases expression ISO RGD:1607086 6480464 Methotrexate results in decreased expression of SKP2 mRNA CTD PMID:24657277 methotrexate multiple interactions ISO RGD:1607086 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of SKP2 mRNA CTD PMID:24657277 methylmercury chloride decreases expression ISO RGD:1607086 6480464 methylmercuric chloride results in decreased expression of SKP2 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1552631 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO RGD:1552631 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO RGD:1552631 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA CTD PMID:31884101 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1552631 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SKP2 mRNA CTD PMID:20061341 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1607086 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [SKP2 protein results in decreased expression of DUSP1 protein] CTD PMID:34697729 nickel atom multiple interactions ISO RGD:1552631 6480464 MT1 affects the reaction [Nickel affects the expression of SKP2 mRNA], MT2 affects the reaction [Nickel affects the expression of SKP2 mRNA] CTD PMID:16166738 nickel dichloride decreases expression ISO RGD:1607086 6480464 nickel chloride results in decreased expression of SKP2 mRNA CTD PMID:17312168 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of SKP2 mRNA CTD PMID:33484710 orlistat multiple interactions ISO RGD:1607086 6480464 [orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein CTD PMID:15138278 orlistat decreases expression ISO RGD:1607086 6480464 orlistat results in decreased expression of SKP2 protein CTD PMID:15138278 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SKP2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SKP2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1552631 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SKP2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SKP2 mRNA CTD PMID:34911549 paclitaxel affects response to substance ISO RGD:1607086 6480464 SKP2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paracetamol decreases expression ISO RGD:1607086 6480464 Acetaminophen results in decreased expression of SKP2 mRNA CTD PMID:21420995 perfluorononanoic acid decreases expression ISO RGD:1607086 6480464 perfluoro-n-nonanoic acid results in decreased expression of SKP2 mRNA CTD PMID:32588087 phenethyl isothiocyanate decreases expression ISO RGD:1607086 6480464 phenethyl isothiocyanate results in decreased expression of SKP2 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1552631 6480464 Phenobarbital affects the expression of SKP2 mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:1607086 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKP2 mRNA CTD PMID:27188386 piroxicam decreases expression ISO RGD:1607086 6480464 Piroxicam results in decreased expression of SKP2 mRNA CTD PMID:21858171 potassium chromate multiple interactions ISO RGD:1607086 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SKP2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1607086 6480464 potassium chromate(VI) results in decreased expression of SKP2 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:1607086 6480464 Potassium Dichromate results in decreased expression of SKP2 protein CTD PMID:23718831 potassium dichromate increases expression ISO RGD:1607086 6480464 Potassium Dichromate results in increased expression of SKP2 protein CTD PMID:23718831 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1552631 6480464 [1 more ... CTD PMID:23626729 progesterone multiple interactions ISO RGD:1607086 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of SKP2 protein CTD PMID:23029392 quercetin decreases expression ISO RGD:1607086 6480464 Quercetin results in decreased expression of SKP2 mRNA CTD PMID:21632981 , PMID:23727915 resveratrol multiple interactions ISO RGD:1607086 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SKP2 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1607086 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver(1+) nitrate increases expression ISO RGD:1607086 6480464 Silver Nitrate analog results in increased expression of SKP2 mRNA CTD PMID:22831968 sirolimus decreases expression ISO RGD:1607086 6480464 Sirolimus results in decreased expression of SKP2 protein CTD PMID:21092744 sodium arsenite increases expression ISO RGD:1607086 6480464 sodium arsenite results in increased expression of SKP2 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite decreases expression ISO RGD:1607086 6480464 sodium arsenite results in decreased expression of SKP2 mRNA CTD PMID:23876855 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of SKP2 mRNA CTD PMID:22110744 sodium tungstate increases expression ISO RGD:1607086 6480464 sodium tungstate(VI) results in increased expression of SKP2 mRNA CTD PMID:26164860 stattic multiple interactions EXP 6480464 stattic inhibits the reaction [EDN1 protein results in increased expression of SKP2 mRNA], stattic inhibits the reaction [EDN1 protein results in increased expression of SKP2 protein] CTD PMID:30670587 sulindac sulfide decreases expression ISO RGD:1607086 6480464 sulindac sulfide results in decreased expression of SKP2 mRNA CTD PMID:16184548 sunitinib decreases expression ISO RGD:1607086 6480464 Sunitinib results in decreased expression of SKP2 mRNA CTD PMID:31533062 tamibarotene decreases expression ISO RGD:1607086 6480464 tamibarotene results in decreased expression of SKP2 mRNA CTD PMID:15498508 tert-butyl hydroperoxide decreases expression ISO RGD:1607086 6480464 tert-Butylhydroperoxide results in decreased expression of SKP2 mRNA CTD PMID:15336504 tert-butyl hydroperoxide decreases methylation ISO RGD:1607086 6480464 tert-Butylhydroperoxide results in decreased methylation of SKP2 intron CTD PMID:29432895 testosterone multiple interactions ISO RGD:1607086 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of SKP2 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1607086 6480464 Testosterone results in decreased expression of SKP2 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1552631 6480464 Carbon Tetrachloride results in increased expression of SKP2 mRNA CTD PMID:31919559 titanium dioxide decreases expression ISO RGD:1552631 6480464 titanium dioxide results in decreased expression of SKP2 mRNA CTD PMID:29264374 toluene 2,4-diisocyanate increases expression ISO RGD:1552631 6480464 Toluene 2, 4-Diisocyanate results in increased expression of SKP2 mRNA CTD PMID:21404309 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SKP2 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1607086 6480464 SKP2 protein affects the susceptibility to Topotecan CTD PMID:16217747 triacsin C decreases expression ISO RGD:1607086 6480464 triacsin C results in decreased expression of SKP2 mRNA CTD PMID:16704987 Tributyltin oxide decreases expression ISO RGD:1552631 6480464 bis(tri-n-butyltin)oxide results in decreased expression of SKP2 mRNA CTD PMID:18958704 , PMID:25270620 trimellitic anhydride increases expression ISO RGD:1552631 6480464 trimellitic anhydride results in increased expression of SKP2 mRNA CTD PMID:19042947 troglitazone decreases response to substance ISO RGD:1607086 6480464 SKP2 protein results in decreased susceptibility to troglitazone CTD PMID:12717389 troglitazone decreases expression ISO RGD:1607086 6480464 troglitazone results in decreased expression of SKP2 mRNA, troglitazone results in decreased expression of SKP2 protein CTD PMID:12717389 more ... tungsten increases expression ISO RGD:1552631 6480464 Tungsten results in increased expression of SKP2 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:1607086 6480464 Urethane results in decreased expression of SKP2 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1607086 6480464 Valproic Acid results in decreased methylation of SKP2 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1607086 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKP2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1607086 6480464 Valproic Acid results in decreased expression of SKP2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1607086 6480464 Valproic Acid affects the expression of SKP2 mRNA CTD PMID:25979313 vincaleukoblastine affects response to substance ISO RGD:1607086 6480464 SKP2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vincristine decreases expression ISO RGD:1607086 6480464 Vincristine results in decreased expression of SKP2 mRNA CTD PMID:23649840